L Borgatta

Summary

Affiliation: Boston University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion
    Nathalie Kapp
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA
    Contraception 73:525-7. 2006
  2. doi request reprint Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 021128, USA
    Contraception 86:567-71. 2012
  3. doi request reprint Relationship of intraamniotic digoxin to fetal demise
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA
    Contraception 81:328-30. 2010
  4. doi request reprint Cervical obstruction complicating second-trimester abortion: treatment with misoprostol
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts, USA
    Obstet Gynecol 113:548-50. 2009
  5. ncbi request reprint Early medical abortion with methotrexate and misoprostol: outcomes and satisfaction among women aged 15-21 years
    L Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine Medical Center, 91 East Concord Street, Boston, MA 02118, USA
    J Pediatr Adolesc Gynecol 14:9-16. 2001
  6. ncbi request reprint A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA
    Contraception 72:358-61. 2005
  7. ncbi request reprint Misoprostol as the primary agent for medical abortion in a low-income urban setting
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine and Boston Medical Center, 85 East Concord Street, 6th Floor, Boston, MA 02118, USA
    Contraception 70:121-6. 2004
  8. ncbi request reprint Pelvic embolization for treatment of hemorrhage related to spontaneous and induced abortion
    L Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine, MA 02118, USA
    Am J Obstet Gynecol 185:530-6. 2001
  9. ncbi request reprint Pregnancies diagnosed during Depo-Provera use
    Lynn Borgatta
    Boston University School of Medicine, Department of Obstetrics and Gynecology, Boston, MA, USA
    Contraception 66:169-72. 2002
  10. ncbi request reprint Intervention rates for placental removal following induction abortion with misoprostol
    Janis Green
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA
    Contraception 76:310-3. 2007

Collaborators

Detail Information

Publications22

  1. ncbi request reprint Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion
    Nathalie Kapp
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA
    Contraception 73:525-7. 2006
    ..This pilot study was designed to evaluate the outcome of medical abortion following simultaneous mifepristone (100 mg) and misoprostol (800 microg)...
  2. doi request reprint Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 021128, USA
    Contraception 86:567-71. 2012
    ..Cervical preparation is recommended before second-trimester abortion. We investigated the use of a pharmacologic method of preparation, mifepristone, as compared to osmotic dilators for surgical abortions at 14-16 weeks...
  3. doi request reprint Relationship of intraamniotic digoxin to fetal demise
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA
    Contraception 81:328-30. 2010
    ..This study was designed to evaluate the effectiveness of intraamniotic injection and the timing of fetal demise after injection...
  4. doi request reprint Cervical obstruction complicating second-trimester abortion: treatment with misoprostol
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts, USA
    Obstet Gynecol 113:548-50. 2009
    ..Leiomyomas may also obstruct the lower uterine segment such that instruments cannot be passed from the vagina to the gestation...
  5. ncbi request reprint Early medical abortion with methotrexate and misoprostol: outcomes and satisfaction among women aged 15-21 years
    L Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine Medical Center, 91 East Concord Street, Boston, MA 02118, USA
    J Pediatr Adolesc Gynecol 14:9-16. 2001
    ..To compare the outcomes of women aged 15-21 yr to those of older women in a multicenter case series of early medical abortion...
  6. ncbi request reprint A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA
    Contraception 72:358-61. 2005
    ..To compare the outcomes of second-trimester induction abortion with misoprostol and hypertonic saline, with and without use of laminaria...
  7. ncbi request reprint Misoprostol as the primary agent for medical abortion in a low-income urban setting
    Lynn Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine and Boston Medical Center, 85 East Concord Street, 6th Floor, Boston, MA 02118, USA
    Contraception 70:121-6. 2004
    ..Among 57 women who reported a time of tissue passage, the mean time from initial misoprostol dose was 8.5 h (95% CI 6.5-13 h)...
  8. ncbi request reprint Pelvic embolization for treatment of hemorrhage related to spontaneous and induced abortion
    L Borgatta
    Department of Obstetrics and Gynecology, Boston University School of Medicine, MA 02118, USA
    Am J Obstet Gynecol 185:530-6. 2001
    ..Presentation of outcomes of pelvic arterial embolization for hemorrhage after spontaneous or induced abortion...
  9. ncbi request reprint Pregnancies diagnosed during Depo-Provera use
    Lynn Borgatta
    Boston University School of Medicine, Department of Obstetrics and Gynecology, Boston, MA, USA
    Contraception 66:169-72. 2002
    ..Although pregnancy during Depo-Provera use is rare, it does occur. These pregnancies are frequently unrecognized until beyond first trimester...
  10. ncbi request reprint Intervention rates for placental removal following induction abortion with misoprostol
    Janis Green
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA
    Contraception 76:310-3. 2007
    ..Many studies of induction abortions report routine operative removal of the placenta after a set time period resulting in high rates of operative procedures...
  11. ncbi request reprint Methods for induced abortion
    Phillip G Stubblefield
    Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts 02118, USA
    Obstet Gynecol 104:174-85. 2004
    ..Fetal intracardiac injection to reduce multiple pregnancies or selectively abort an anomalous twin is accepted therapy. Outcomes for the remaining pregnancy have improved with experience...
  12. ncbi request reprint Alternatives to mifepristone for early medical abortion
    N L Moreno-Ruiz
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA
    Int J Gynaecol Obstet 96:212-8. 2007
    ..To review published reports of first-trimester medical abortion regimens that do not include mifepristone...
  13. ncbi request reprint Mifepristone in second-trimester medical abortion: a randomized controlled trial
    Nathalie Kapp
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts, USA
    Obstet Gynecol 110:1304-10. 2007
    ..To investigate the adjunctive use of mifepristone in second-trimester induction abortions using misoprostol 1 day after feticidal digoxin...
  14. ncbi request reprint Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol
    Angela Y Chen
    Department of Obstetrics and Gynecology, Boston University School of Medicine, MA 02118, USA
    Contraception 73:415-9. 2006
    ..This study examines bleeding pattern following medication-induced termination of pregnancy, comparing two different dosing schedules of mifepristone and misoprostol...
  15. ncbi request reprint Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy
    Tuangsit Wataganara
    Department of Pediatrics, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Fertil Steril 81:638-44. 2004
    ..To determine if first-trimester elective termination of pregnancy affects cell-free fetal DNA (fDNA) levels in maternal plasma...
  16. ncbi request reprint Short-term clearance of cell-free nucleic acids after first-trimester termination of pregnancy
    Young Ju Jeong
    Division of Genetics, Department of Pediatrics, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Fertil Steril 88:730-3. 2007
    ....
  17. ncbi request reprint Circulating cell-free fetal nucleic acid analysis may be a novel marker of fetomaternal hemorrhage after elective first-trimester termination of pregnancy
    Tuangsit Wataganara
    Division of Genetics, Department of Pediatrics, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Ann N Y Acad Sci 1022:129-34. 2004
    ..Measurement of cell-free fetal nucleic acid levels in maternal plasma may have clinical application as a novel marker of FMH after 9 weeks of gestation...
  18. doi request reprint Relationship of obesity to outcome of medical abortion
    Melissa A Strafford
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA
    Am J Obstet Gynecol 200:e34-6. 2009
    ..The purpose of this study was to compare the outcome of medical abortion for obese women and nonobese women...
  19. ncbi request reprint Changes of cell-free fetal DNA in maternal plasma after elective termination of pregnancy
    Tuangsit Wataganara
    Division of Genetics, Department of Pediatrics, Tufts New England Medical Center, Boston, MA 02111, USA
    Clin Chem 51:217-9. 2005
  20. ncbi request reprint Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels
    Tuangsit Wataganara
    Division of Genetics, Department of Pediatrics, Institute of Clinical Research and Health Policy Studies, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Obstet Gynecol 104:545-50. 2004
    ..We conducted this study to estimate the effect of selected demographic factors on fetal DNA levels in the first and second trimesters of pregnancy...
  21. ncbi request reprint Study design to evaluate the safety and effectiveness of hormonal contraception for women
    Nathalie Kapp
    Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    Clin Obstet Gynecol 50:850-67. 2007
    ..Observational studies, experimental studies, and meta-analysis in hormonal contraception are also reviewed...
  22. doi request reprint Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial
    Mitchell D Creinin
    Department of Obstetrics, Gynecology and Reproductive Sciences and Magee Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213 3180, USA
    Obstet Gynecol 111:267-77. 2008
    ..To understand if the contraceptive ring or patch was more acceptable, as measured primarily by continuation, to women using an oral contraceptive and interested in a nondaily, combined hormonal contraceptive...